Published in J Clin Invest on January 01, 1994
TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol (2008) 3.42
Cytokines in asthma. Thorax (1999) 2.64
Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med (2010) 2.40
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest (1995) 2.20
Glucocorticosteroids: current and future directions. Br J Pharmacol (2011) 1.85
Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med (1995) 1.83
Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med (2008) 1.68
Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med (1997) 1.61
Management of severe asthma in children. Lancet (2010) 1.60
Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med (1995) 1.47
Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol (2008) 1.44
The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med (2013) 1.36
The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Mol Med (1996) 1.35
Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc Natl Acad Sci U S A (2005) 1.31
Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol (2007) 1.13
Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol (2013) 1.09
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol (2000) 1.06
IFN-gamma reverses IL-2- and IL-4-mediated T-cell steroid resistance. Am J Respir Cell Mol Biol (2008) 1.00
The melatonin-cytokine connection in rheumatoid arthritis. Ann Rheum Dis (2005) 0.99
Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells. J Clin Immunol (2012) 0.96
Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance. Neuroimmunomodulation (2008) 0.92
Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care (2004) 0.91
Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma. Multidiscip Respir Med (2012) 0.90
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells. J Immunother (2005) 0.88
Th2 cytokine-induced upregulation of 11beta-hydroxysteroid dehydrogenase-1 facilitates glucocorticoid suppression of proasthmatic airway smooth muscle function. Am J Physiol Lung Cell Mol Physiol (2009) 0.86
Pro-asthmatic cytokines regulate unliganded and ligand-dependent glucocorticoid receptor signaling in airway smooth muscle. PLoS One (2013) 0.86
Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by pro-inflammatory/cytotoxic lymphocytes. Respir Res (2015) 0.86
Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J Clin Invest (1998) 0.85
Characterization of the antiallergic drugs 3-[2-(2-phenylethyl) benzoimidazole-4-yl]-3-hydroxypropanoic acid and ethyl 3-hydroxy-3-[2-(2-phenylethyl)benzoimidazol-4-yl]propanoate as full aryl hydrocarbon receptor agonists. Chem Res Toxicol (2008) 0.84
Smoking in asthma is associated with elevated levels of corticosteroid resistant sputum cytokines-an exploratory study. PLoS One (2013) 0.83
Glucocorticoid sensitivity and proinflammatory cytokines pattern in pemphigus. J Clin Immunol (2012) 0.82
Clinical and molecular aspects of glucocorticoid resistant asthma. Ther Clin Risk Manag (2007) 0.81
In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis. Arthritis Res Ther (2012) 0.80
IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNF-alpha production by human mononuclear blood cells. Br J Pharmacol (1999) 0.79
The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation. Virology (2013) 0.78
Is there a role for glucocorticoid receptor beta in asthma? Respir Res (2000) 0.77
Difficult-to-treat asthma, is it really difficult? Ann Thorac Med (2011) 0.76
Integrin and GPCR Crosstalk in the Regulation of ASM Contraction Signaling in Asthma. J Allergy (Cairo) (2012) 0.76
Steroid Resistance of Airway Type 2 Innate Lymphoid Cells (ILC2s) from Severe Asthma: The Role of Thymic Stromal cell Lymphopoietin (TSLP). J Allergy Clin Immunol (2017) 0.76
Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD. Mediators Inflamm (1998) 0.75
Heterogeneity of glucocorticoid resistance in patients with bronchial asthma. Int J Biomed Sci (2010) 0.75
Is there a role for treatment of asthma with omalizumab? Arch Dis Child (2003) 0.75
Nuclear bioavailability of the glucocorticoid receptor in a pediatric asthma cohort with variable corticosteroid responsiveness. Pediatr Res (2015) 0.75
Steroid-resistant asthma. West J Med (1995) 0.75
17-oxo-DHA displays additive anti-inflammatory effects with fluticasone propionate and inhibits the NLRP3 inflammasome. Sci Rep (2016) 0.75
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med (1992) 11.90
Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell (1990) 6.84
Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science (1990) 6.72
Nuclear factor of activated T cells contains Fos and Jun. Nature (1992) 3.43
Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis (1992) 2.89
Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet (1986) 2.20
Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis (1991) 1.84
Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed) (1981) 1.75
Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev (1987) 1.68
Steroid resistance in bronchial asthma. Ann Intern Med (1968) 1.32
Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis (1991) 1.30
Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest (1982) 1.18
Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest (1991) 1.18
Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis (1992) 1.11
Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol (1992) 1.11
Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin Pharmacol Ther (1990) 1.06
Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol (1991) 1.01
Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. J Pediatr (1991) 0.96
Glucocorticoid receptors and actions. Am Rev Respir Dis (1990) 0.94
Steroid resistance in asthma: our current understanding. Pediatr Pulmonol (1992) 0.91
Anti-inflammatory drugs in the treatment of allergic disease. Med Clin North Am (1992) 0.85
High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response. J Allergy Clin Immunol (1992) 0.83
Endogenous cortisol regulates immunoglobulin E-dependent late phase reactions. J Clin Invest (1992) 0.81
Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet (2000) 4.19
Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med (1996) 4.03
Superantigens and their potential role in human disease. Adv Immunol (1993) 3.88
Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA (2001) 3.21
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med (2000) 3.08
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest (1994) 2.88
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation (1994) 2.80
The revised two-factor Study Process Questionnaire: R-SPQ-2F. Br J Educ Psychol (2001) 2.72
Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med (1997) 2.64
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography. Ann Intern Med (1997) 2.38
Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol (1992) 2.29
Inhaled glucocorticoid therapy in children: how much is safe? Pediatr Pulmonol (1992) 2.18
Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science (1976) 2.17
Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol (1993) 2.09
Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet (1994) 2.00
Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. J Exp Med (1988) 1.97
Onset and persistence of childhood asthma: predictors from infancy. Pediatrics (2001) 1.91
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol (1998) 1.87
Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis (1991) 1.84
Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med (1995) 1.83
Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest (1986) 1.81
Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun (2001) 1.80
Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol (1997) 1.75
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med (1986) 1.74
In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol (1994) 1.70
Predicting worsening asthma control following the common cold. Eur Respir J (2008) 1.70
Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy (2010) 1.70
Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol (1991) 1.65
Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol (1999) 1.62
Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med (1997) 1.61
Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study. Ann Intern Med (1991) 1.61
Production of IgE-potentiating factor in man by T cell lines bearing Fc receptors for IgE. Eur J Immunol (1984) 1.59
Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med (2001) 1.58
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med (1997) 1.58
Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol (2000) 1.56
Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J (1997) 1.53
Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatr (1998) 1.52
Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol (1996) 1.52
Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol (1994) 1.52
Zileuton: the first 5-lipoxygenase inhibitor for the treatment of asthma. Ann Pharmacother (1996) 1.52
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51
Localization of antigenic determinants in the polypeptide chains of collagen. Science (1969) 1.51
Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol (1998) 1.50
In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol (1996) 1.48
Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med (1998) 1.47
Induction of human IgE synthesis by a factor derived from T cells of patients with hyper-IgE states. J Immunol (1983) 1.46
Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental? Am Rev Respir Dis (1991) 1.46
Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol (1983) 1.46
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest (1987) 1.45
Reliability of the model MC-311 MDI chronolog. J Allergy Clin Immunol (1999) 1.44
Integrated backscatter for quantification of left atrial spontaneous echo contrast. J Am Coll Cardiol (1996) 1.43
Inhaled therapy in infants: why not nebulize glucocorticoids? Pediatr Pulmonol (1992) 1.43
Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med (1999) 1.43
Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest (1990) 1.42
Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med (1990) 1.41
Alternative therapy in severe asthma. J Asthma (1992) 1.40
High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med (2001) 1.39
Early intervention for childhood asthma: inhaled glucocorticoids as the "preferred" medication. J Allergy Clin Immunol (1998) 1.39
Legionella and Pneumocystis pneumonias in asthmatic children on high doses of systemic steroids. Pediatr Pulmonol (1994) 1.38
Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol (1992) 1.36
Differential requirements of B cells from normal and allergic subjects for the induction of IgE synthesis by an alloreactive T cell clone. J Exp Med (1985) 1.35
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr (1986) 1.34
Metropolitan home living conditions associated with indoor endotoxin levels. J Allergy Clin Immunol (2001) 1.33
Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol (1995) 1.33
Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol (1983) 1.31
The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol (1999) 1.29
Airways inflammation in nocturnal asthma. Am Rev Respir Dis (1991) 1.26
Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med (1996) 1.25
Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J Immunol (1994) 1.25
Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol (1982) 1.24
Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol (1996) 1.23
Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature (1986) 1.21
GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy (1998) 1.20
Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol (2001) 1.19
Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. Int Arch Allergy Immunol (2001) 1.18
Enumeration of T cell subsets in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol (1981) 1.17
Is there a role for glucocorticoid receptor beta in glucocorticoid-dependent asthmatics? Am J Respir Crit Care Med (2000) 1.17
Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates. J Pediatr (1980) 1.13
Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol (2001) 1.13
Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol (1997) 1.12
Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol (1992) 1.11
Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol (1996) 1.11
Allergen sensitization through the skin induces systemic allergic responses. J Allergy Clin Immunol (2000) 1.10
Induction of IgE synthesis in normal human B cells. Sequential requirements for activation by an alloreactive T cell clone and IgE-potentiating factors. J Exp Med (1986) 1.10